ATE352545T1 - Arylthiazolidindion-derivate - Google Patents

Arylthiazolidindion-derivate

Info

Publication number
ATE352545T1
ATE352545T1 AT98963283T AT98963283T ATE352545T1 AT E352545 T1 ATE352545 T1 AT E352545T1 AT 98963283 T AT98963283 T AT 98963283T AT 98963283 T AT98963283 T AT 98963283T AT E352545 T1 ATE352545 T1 AT E352545T1
Authority
AT
Austria
Prior art keywords
arylthiazolidindone
derivatives
ppar
thiazolidinediones
hypertriglyceridemia
Prior art date
Application number
AT98963283T
Other languages
English (en)
Inventor
Soumya P Sahoo
Richard L Tolman
Wei Han
Jeffrey Bergmann
Conrad Santini
Vicki R Lombardo
Ranjit Desai
Julia K Boueres
Dominick F Gratale
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9816279.5A external-priority patent/GB9816279D0/en
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of ATE352545T1 publication Critical patent/ATE352545T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/44—Two oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT98963283T 1997-12-19 1998-12-18 Arylthiazolidindion-derivate ATE352545T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6827197P 1997-12-19 1997-12-19
GBGB9816279.5A GB9816279D0 (en) 1998-07-27 1998-07-27 Arylthiazolidinedione derivatives
US10523898P 1998-10-22 1998-10-22

Publications (1)

Publication Number Publication Date
ATE352545T1 true ATE352545T1 (de) 2007-02-15

Family

ID=27269416

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98963283T ATE352545T1 (de) 1997-12-19 1998-12-18 Arylthiazolidindion-derivate

Country Status (21)

Country Link
EP (1) EP1040102B1 (de)
JP (1) JP3373198B2 (de)
KR (1) KR20010033355A (de)
CN (1) CN1282325A (de)
AT (1) ATE352545T1 (de)
AU (1) AU740733B2 (de)
BG (1) BG104602A (de)
BR (1) BR9813801A (de)
CA (1) CA2315397C (de)
DE (1) DE69836980T2 (de)
EA (1) EA200000687A1 (de)
ES (1) ES2281146T3 (de)
HU (1) HUP0101366A2 (de)
ID (1) ID24878A (de)
IL (1) IL136138A0 (de)
IS (1) IS5506A (de)
NO (1) NO20003112L (de)
PL (1) PL340958A1 (de)
SK (1) SK9212000A3 (de)
TR (1) TR200001753T2 (de)
WO (1) WO1999032465A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9824614D0 (en) 1998-11-11 1999-01-06 Glaxo Group Ltd Chemical compounds
EP1053989B1 (de) * 1999-05-20 2007-07-25 Ciba SC Holding AG Hydroxydiphenyletherverbindungen
AU5876900A (en) * 1999-06-18 2001-01-09 Merck & Co., Inc. Process for making arylthiazolidinedione derivatives
US6399640B1 (en) * 1999-06-18 2002-06-04 Merck & Co., Inc. Arylthiazolidinedione and aryloxazolidinedione derivatives
US7041691B1 (en) 1999-06-30 2006-05-09 Amgen Inc. Compounds for the modulation of PPARγ activity
US6417212B1 (en) 1999-08-27 2002-07-09 Eli Lilly & Company Modulators of peroxisome proliferator activated receptors
AU1303301A (en) * 1999-11-10 2001-06-06 Takeda Chemical Industries Ltd. Body weight gain inhibitors
US20030171399A1 (en) 2000-06-28 2003-09-11 Tularik Inc. Quinolinyl and benzothiazolyl modulators
AU2001298065A1 (en) * 2001-01-12 2003-09-02 Abbott Laboratories Process for the preparation of matrix metalloproteinase inhibitors
WO2002087580A1 (en) * 2001-04-25 2002-11-07 Takeda Chemical Industries, Ltd. Abc expression promoters
US7125865B2 (en) * 2002-07-25 2006-10-24 Merck & Co., Inc. Therapeutic compounds for treating dyslipidemic conditions
KR100736955B1 (ko) * 2002-08-30 2007-07-09 에프. 호프만-라 로슈 아게 Ｐｐａｒ알파 및 ｐｐａｒ감마 작용제로서의 신규한 2-아릴티아졸 화합물
PT1567493E (pt) * 2002-11-26 2009-04-09 Pfizer Prod Inc Activadores de ppar
CN1319956C (zh) * 2003-09-12 2007-06-06 深圳市海粤门生物科技开发有限公司 一种噻唑烷二酮的衍生物及其药用制剂的制备方法和应用
WO2005042478A2 (en) * 2003-09-19 2005-05-12 Janssen Pharmaceutica, N.V. 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
DE602004028500D1 (de) 2003-09-19 2010-09-16 Janssen Pharmaceutica Nv 4-((phenoxyalkyl)thio)-phenoxyessigsäuren und analoga
DE602005001265T2 (de) * 2004-01-20 2008-01-31 Merck & Co., Inc. Antidiabetische oxazolidindione und thiazolidindione
WO2006138328A1 (en) * 2005-06-14 2006-12-28 Merck & Co., Inc. Process for the production of antidiabetic oxazolidinediones
CA2612765A1 (en) 2005-07-06 2007-01-18 Merck And Co., Inc. Antidiabetic oxazolidinediones and thiazolidinediones
JP2009502783A (ja) * 2005-07-20 2009-01-29 メルク エンド カムパニー インコーポレーテッド 抗糖尿病性オキサゾリジンジオン及びチアゾリジンジオン
MX2009013332A (es) 2007-06-08 2010-01-25 Mannkind Corp Inhibidores de ire-1 alfa.
CN104987314A (zh) * 2015-07-14 2015-10-21 佛山市赛维斯医药科技有限公司 含苯并异恶唑和末端硝基苄基类结构的化合物及其用途
CN105001174A (zh) * 2015-07-14 2015-10-28 佛山市赛维斯医药科技有限公司 含苯并异恶唑和末端腈基苄基类结构的化合物及其用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3053490B2 (ja) * 1991-02-25 2000-06-19 杏林製薬株式会社 チアゾリジン−２，４−ジオン誘導体とその塩及び製造法
JP3906935B2 (ja) * 1995-12-18 2007-04-18 杏林製薬株式会社 Ｎ−置換ジオキソチアゾリジルベンズアミド誘導体及びその製造法
AU721452B2 (en) * 1996-02-02 2000-07-06 Merck & Co., Inc. Antidiabetic agents
JP2002515865A (ja) * 1996-02-02 2002-05-28 メルク エンド カンパニー インコーポレーテッド 抗糖尿病薬
WO1997028137A1 (en) * 1996-02-02 1997-08-07 Merck & Co., Inc. Heterocyclic derivatives as antidiabetic and antiobesity agents
US5801173A (en) * 1996-05-06 1998-09-01 Dr. Reddy's Research Foundation Heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
DE69836980T2 (de) 2007-11-15
EP1040102A1 (de) 2000-10-04
JP3373198B2 (ja) 2003-02-04
BG104602A (bg) 2001-01-31
HUP0101366A2 (hu) 2001-09-28
EP1040102A4 (de) 2002-11-27
TR200001753T2 (tr) 2000-11-21
BR9813801A (pt) 2000-10-03
CA2315397A1 (en) 1999-07-01
CA2315397C (en) 2007-08-07
KR20010033355A (ko) 2001-04-25
WO1999032465A1 (en) 1999-07-01
JP2001526278A (ja) 2001-12-18
ID24878A (id) 2000-08-31
ES2281146T3 (es) 2007-09-16
NO20003112L (no) 2000-08-18
AU1833499A (en) 1999-07-12
EA200000687A1 (ru) 2000-12-25
CN1282325A (zh) 2001-01-31
SK9212000A3 (en) 2001-02-12
NO20003112D0 (no) 2000-06-16
IS5506A (is) 2000-05-23
IL136138A0 (en) 2001-05-20
AU740733B2 (en) 2001-11-15
DE69836980D1 (de) 2007-03-15
EP1040102B1 (de) 2007-01-24
PL340958A1 (en) 2001-03-12

Similar Documents

Publication Publication Date Title
ATE352545T1 (de) Arylthiazolidindion-derivate
EP1194146A4 (de) Arylthiazolidinedione und aryloxa zolidinedion-derivate
AU7705601A (en) N-substituted indoles useful in the treatment of diabetes
WO2002026729A3 (en) Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders
WO2002060434A3 (en) Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders
WO2002060388A3 (en) Acyl sulfamides for treatment of obesity, diabetes and lipid disorders
NO20015607D0 (no) Glukagonantagonister/inversagonister
IS5194A (is) Notkun þíasólídíndíonafleiða við meðferð á fjölblöðrueggjastokkaheilkennum og þungunarsykursýki
DE69625926D1 (de) Absorbierende zusammensetzung und saugfähiges wegwerfkleidungsstück, welches dasselbe enthält
DK0830377T4 (da) Glucagon-lignende peptid-2 og terapeutisk anvendelse deraf
NO894296L (no) Fremgangsmaate for behandling av leddgikt og betennelsessykdommer.
IT8919964A0 (it) Proteine inibenti i ribosomi e loro derivati.
YU39598A (sh) Upotreba duloksetina i njegova farmaceutska smeša
NO975636L (no) Farmasöytisk sammensetning for fremming av osteogenese
NO996264D0 (no) Behandling av diabetes med tiazolidindion og sulfonylurea
NO20000229L (no) Behandling av diabetes med tiazolidindion og sulfonylurea
EP0456842A4 (en) Medicinal application of m-csf
ECSP993022A (es) Derivados de ariltiazolidindiona
AR018898A1 (es) Derivados de 5-aril-2,4-tiazolidindiona, una composicion farmaceutica que los comprende y el uso de los mismos para la fabricacion de un medicamento
DE69526731D1 (en) Hypocholesterolämische,antiatherosklerotische und hypotriglyceridämische mercaptoacetylamid-derivate
ID20165A (id) Penggunaan asam 2-(3,4-dimetoksisinamoil)aminobenzoat untuk pembuatan obat untuk pengobatan atau pencegahan restenosis
DK0458892T3 (da) Anvendelse af chlormethiazol ved fremstillingen af et medikament til forebyggelsen og/eller behandlingen af neurodegeneration
DOP2001000256A (es) Derivados del acidobenzopirancarboxilico para el tratamineto de la diabetes y los trastornos de lipidos.
EP0543076A3 (en) Wheat alpha-amylase inhibitor for the treatment of diabetes
NO910704D0 (no) Fremgangsmaate for behandling av svovel-, jern- og sinkholdige metallurgiske biprodukter og/eller avfallsprodukter.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties